Raphael Pharmaceutical Inc. (RAPH) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$779.0K2021: -$1.42M2022: -$759.0K2023: -$1.20M2024: -$532.0K2025: -$210.0K-$210.0K
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$210.0K+60.5%
2024-$532.0K+55.8%
2023-$1.20M-58.5%
2022-$759.0K+46.5%
2021-$1.42M-82.2%
2020-$779.0K